eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments; Correction
Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments; Correction
Document ID:
FDA-2012-N-0780-0003
Document Type:
Proposed Rule
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2012-22793
CFR Citation:
21 CFR Chapter I
View Document:
Details Information
Document Subtype:
Correction
Received Date:
September 17 2012, at 12:00 AM Eastern Daylight Time
Start-End Page:
57055 - 57055
Page Count:
1
Comment Start Date:
September 17 2012, at 12:00 AM Eastern Standard Time
Comments
Total:
0
No comments posted.
Related Documents
More
Total:
15
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Food and Drug Administration Safety and Innovation Act Title VII--Drug Supply Chain; Standards for Admission of Imported Drugs, Registration of Commercial Importers and Good Importer Practices; Notification of Public Meeting; Request for Comments
Administrative Detention under the Food and Drug Administration Safety and Innovation Act
Tobacco Product Manufacturing Practice; Establishment of a Public Docket
Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments
See FDA-2012-N-0780-0001
Revision of Organization and Conforming Changes to Regulations
Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice; Public Hearing; Request for Comments
Preemption Review
Revised Guidance on Marketed Unapproved Drugs; Availability: Marketed New Drugs Without Approved NDAs or ANDAs
Periodic Reviews of Existing Regulations
Food Safety Modernization Act, Focus on Preventive Controls for Facilities; Notice of Public Meeting
Revision of Organization and Conforming Changes to Regulations
Withdrawal of Certain Proposed Rules and Other Proposed Actions
Regulatory New Drug Review: Solutions for Study Data Exchange Standards; Meeting; Request for Comments; Correction
Details Information
Comments
Related Documents
More